BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Other news to note for July 5, 2023

July 5, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Affidea, Biocardia, Guardant, Microba Life Sciences, Sonic Healthcare.
Read More

Financings for July 5, 2023

July 5, 2023
Med-tech firms raising money in public or private financings, including: Biocomposites, Liberate Medical, Nousq, Renovos, Ventureblick.
Read More

Appointments and advancements for July 5, 2023

July 5, 2023
New hires and promotions in the med-tech industry, including: Hoya, Oncoinvent, Pentax Medical.
Read More

Regulatory actions for July 5, 2023

July 5, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Iaso, Mediwound, Moderna, Nevakar, Injectables, Skyline, Systimmune, Zealand.
Read More

Other news to note for July 5, 2023

July 5, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Altamira, Biocon, Biocytogen, Daré, Edirna, Evotec, Heget, Gilead, Kiora, Lucy, Organon, Pheon, RVL, Sarepta, Sirnaomics, Teva, Wesana.
Read More

In the clinic for July 5, 2023

July 5, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Canbridge, Daiichi Sankyo, Genentech, Horizon, Krystal, Nicox, NLS, Sosei, Toragen, Vogenx, Zealand.
Read More

Financings for July 5, 2023

July 5, 2023
Biopharmas raising money in public or private financings, including: Compass, Fluogide, IGM.
Read More

Appointments and advancements for July 5, 2023

July 5, 2023
New hires and promotions in the biopharma industry, including: Akari, Coya, Cytovation, EMD Serono, FSD, Oncoinvent, Small, Visiox.
Read More

Med-tech gainers and losers for June 26-30, 2023

July 3, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Other news to note for July 3, 2023

July 3, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alma, Biotricity, Centogene, Fortrea, Labcorp, Lca Automation, Lifera, Lumiraxx, Mediwound, Novacyt, Rewalk Robotics, Shl Medical, Yourgene Health.
Read More
Previous 1 2 … 764 765 766 767 768 769 770 771 772 … 1809 1810 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 15, 2026.
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • Illustration of Lactobacillus

    Microbiota modulates the antidepressant effects of GLP-1 analogues

    BioWorld Science
    Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
  • Genome sequence map

    EHA 2026: With new lenses, a changing view on pediatric cancers

    BioWorld
    In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
  • Microscopic image of chronic myeloid leukemia

    Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

    BioWorld
    Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing